Iron deficiency anemia iron deficiency anemia,
Conditions
Interventions
In intervention group,
patients will receive ferrous sulphate 2 tab od (400 mg) on alternate day for 3 months,In control group,
patients will receive ferrous sulphate 1 tab (200 mg) bid everyday for 3 months
Experimental Drug,Active Comparator Drug
Ferrous sulphate 400 mg alternate days ,Ferrous sulphate 200 mg twice daily
Sponsors
Faculty of medicine, Chulalongkorn University
Division of Hmeatolo,
Department of Internal medicine,
Faculty of medicine,
Chulalongkorn University
Eligibility
Sex/Gender
Female
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: 1. Women , age 18-50 yrs 2. Dx of Iron deficiency anemia in KCMH by Hb 2 g/dl (if baseline Hb was known) with serum ferritin < 30 mcg/L 3. No Hx of blood transfusion or donation in 3 months PTA
Exclusion criteria
Exclusion criteria: 1. Concomitant major chronic diseases or inflammatory diseases Ex. Chronic kidney disease, Chronic heart disease, malignancy or poor controlled DM, morbid obesity, active infection 2. Pregnancy or Lactation 3. Gastrectomy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in hemoglobin at day 30 of treatment The proportion of patients with increased Hb levels > 2 g/dl | — |
Secondary
| Measure | Time frame |
|---|---|
| An increase in hemoglobin levels from baseline 3 months Hemoglobin levels,Proportion of patients with hemoglobin turn normal level 3 months Hemoglobin level ,Number of patient with hemoglobin level increase > = 1 g/dl 30 days Hemoglobin level before and after supplement 1 mo ,Serum ferritin levels 30 days and 3 months Mean of serum ferritin after treatment,Compliance 1 month and 3 month visit number of pills intake,drug side effects severity 1 month and 3 month visit nausea vomitting scale, others as record | — |
Countries
Thailand
Contacts
Public ContactNoppacharn Uaprasert
Faculty of Medicine, Chulalongkorn University
Outcome results
None listed